- JP-listed companies
- PhoenixBio Co.,Ltd.
- Income statement
PhoenixBio Co.,Ltd.JP:6190
Market cap
¥2B
P/E ratio
18x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 794 | 980 | 1,153 | 881 | 1,217 | 1,229 | 902 | 1,228 | 1,311 | 1,014 | 1,325 | 2,124 | 1,715 | 1,541 |
| Cost of revenue | - | - | - | 268 | 388 | 389 | 397 | 377 | 445 | 425 | 597 | 568 | 520 | 424 |
| Gross profit | - | - | - | 613 | 829 | 840 | 506 | 851 | 866 | 588 | 728 | 1,556 | 1,195 | 1,118 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 51 | 190 | 142 | -269 | -312 | -147 | -277 | -168 | 508 | 11 | -142 |
| Operating expenses | - | - | - | 563 | 638 | 698 | 774 | 1,163 | 1,013 | 865 | 895 | 1,048 | 1,184 | 1,260 |
| Income before tax | -237 | -60 | 51 | 63 | 149 | 133 | -267 | -280 | -125 | -224 | -128 | 511 | 44 | -155 |
| Provision for income taxes | - | - | - | 6 | 22 | 2 | 3 | 2 | -2 | 14 | -5 | 17 | 33 | 16 |
| Net income | -240 | -62 | 144 | 57 | 125 | 128 | -271 | -297 | -416 | -238 | -388 | 493 | 26 | -449 |
| Earnings per share | -12.29 | -2.91 | 51.63 | 22.72 | 49.32 | 44.43 | -93.36 | -101.96 | -141.84 | -73.6 | -117.5 | 145.23 | 6.98 | -110.99 |
| Diluted EPS | - | - | - | - | 48.42 | 44.17 | - | - | - | - | - | 97.29 | - | - |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |